What We Do » Licence Overview » Products Licensed » PATENTS RELATED TO DARUNAVIR


In September 2010, the MPP received its first licence from the United States National Institutes of Health (NIH) for patents related to the HIV medicine darunavir (DRV). However, there may be additional patents on darunavir which have not been licensed to the MPP. In addition, the MPP collaborated with Janssen in announcing an expansion of its commitment not to enforce patents on paediatric darunavir in May 2015.

This website uses cookies to ensure you get the best experience on our website. Learn More